survey suggest near-term risk impella
follow present impella aha survey cardiologist
percept data impact util mount defens
neg find respond entir dismiss
overal chang impella use suggest survey sinc aha data
lower number point higher risk near-term
reflect lower price target
impella survey aha non-ev survey cardiologist gaug
impact two present aha compar impella intra-aort balloon pump
iabp key find respond awar data major
view import influenc util howev respond mix
quality/rigor data term impact practic quarter respond
expect reduc impella util averag declin ask
impact broader clinic commun half thought present
would neutral half neg use impella
survey suggest near-term uncertainti risk impella number survey
overal suggest continu challeng weight averag chang
impella use respond survey point growth popul
expect averag declin averag increas pictur
snapshot subject uncertainti come survey aggreg
suggest risk near-term number among rang possibl see
come quarter abl address issu reced put
growth back track user decreas util other result
growth still doubl digit growth model next coupl
quarter growth turn well model us
point conced risk like downsid forecast
leav pend expect updat compani come
lower price target stay buy number chang
lower price target sale reflect near-
term uncertainti keep us posit continu confid long term
market impella big under-penetrated reimburs support
competit near term clearli test resolv move earli
adopt broader user base prove difficult two controversi studi
ad uncertainti part educ market innov
product side collect clinic data support use growth pick
clear lot reason believ eventu willand
keep us buy
estim reflect account
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
estim reflect account
ww impella growth sustain
us german market adopt continu
gradual penetr japan
estim factor contribut stemi
rapid uptak impella
commerci launch japan faster expect
acceler roll-out germani
upsid stemi patient opportun begin
base sale
ww impella growth slow lower adopt
limit penetr japan
slow roll-out germani
stemi studi fail show benefit impella
competit enter short-run
base sale
best growth profil med-tech
impella target market less
indic
current
geographi technolog pipelin
penetr
expand
support secur reimburs
competitor sight least three four year
updat us reimburs code
pleas see import disclosur inform page report
survey find six chart near-term uncertainti
find respond awar two present aha last month nearli half consid result
two studi import inform util impella treat patient cardiogen shock cs practic
sentiment qualiti rigor studi aha mix survey respond expect decreas
util impella cs patient averag declin impella use among note one increas
note increas util also suggest growth impella group
exhibit respond awar aha data present
exhibit import aha data inform clinic util
exhibit sentiment qualiti rigor data aha
exhibit clinic util impella cs patient
exhibit quantif chang util impella
pleas see import disclosur inform page report
ormorew survey ic css gc last year respond util impella support treat patient cs present respond awar present aha particip consid two studi importantin inform util impella treat cs patient percept rigor qualiti data present aha evenli distribut particip decreas util impella treat patient cs follow data present aha last month more- chang particip seen decreas util impella treat patient cs follow data present aha last month equiti research
retrospect studi leav mani unansw question stand sharp contrast
data set
two present american heart associ meet novemb retrospect studi larg databas
use propens match compar impella iabp suggest use impella associ higher risk vs iabp
first also publish circul retrospect analysi patient data includ broad patient popul
acut mi cardiogen shock cs stemi nstemi premier healthcar databas undergo pci impella
iabp across hospit paper conclud wide variabl outcom across hospit
match use propens score adjust impella show higher rate mortal odd bleed
stroke vs iabp differ compar two patient popul address propens match
includ impella patient older iabp patient vs significantli larger portion impella patient
prior histori risk factor includ diabet vs dyslipidemia vs hypertens vs
smoke vs congest heart failur factor exclud paper detail usag
impella devic includ impella implement pre post pci well degre shock patient exhibit
second paper also retrospect propensity-match analysi acute-mi patient cs undergo pci
nation cardiovascular data registri conclud use impella associ higher rate in-hospit death
vs major bleed vs compar iabp match group pair patient like first paper
risk unmeasur confound variabl howev includ homogen patient popul ncdr
also appear surfac match patient popul much closer circul paper analysi
publish detail analysi known
high level studi fraught potenti flaw includ heterogen underli clinic condit non-measur
confound variabl lack insight model use match also stark contrast mass data
compil date clinic benefit impella
two trial suggest use impella higher risk iabp spent last decad gather thousand
data point clinic trial registri demonstr benefit impella protect trial includ
patient continu show benefit impella reduc major advers cardiac cerebrovascular event macc
compar iabp moreov impella qualiti iq databas captur impella implant cvad registri
pre post approv studi patient addit detroit cardiogen shock initi csi found
hospit michigan sinc detroit csi grown nation initi brand nation csi
systemat algorithm treat right patient within specifi treatment window ncsi show surviv
nativ heart recoveri improv upon histor surviv rate ami cardiogen shock follow trend inova
heart vascular institut implement use impella recent present ami cardiogen shock surviv day rise
ordinarili paper might lesser import era growth slow ostens next wave
potenti user perceiv impella difficult riski without enough support datath headlin ad hurdl
overcom
pleas see import disclosur inform page report
assess clinic import qualiti data aha
gaug impact near-term growth outlook impella two aha present survey intervent
cardiologist cardiac surgeon gener cardiologist
survey found data aha much focu clinic commun survey respond
awar present moreov nearli half particip consid result two studi import
inform util impella treat cardiogen shock patient practic
also other point flaw two studi clinic commun provid sober perspect
survey found doctor percept rigor qualiti retrospect analys present evenli distribut
high qualiti rigor low qualiti low qualiti rigor respond mid-
exhibit clinic import data aha
exhibit sentiment qualiti rigor data aha
pleas see import disclosur inform page report
particip consid two studi importantin inform util impella treat cs patient percept rigor qualiti data present aha evenli distribut equiti research
impact clinic util impella expect follow data present
aha
next ask result impact clinic util impella survey found doctor decreas
util impella treat patient cardiogen shock data said chang note increas
ask magnitud chang major report chang clinic util impella patient
cardiogen shock doctor survey seen decreas rang util note
increas
aggreg combin chang util popul expect averag declin expect
exhibit clinic util impella cs patient
exhibit quantif chang util impella
pleas see import disclosur inform page report
